乳腺癌放疗中食管受照剂量:2010-2020年发表数据的系统综述
该系统综述汇总了2010-2020年间18个国家112个乳腺癌放疗方案的食管剂量数据。部分乳腺照射和乳腺/胸壁放疗的食管平均剂量通常低于2 Gy,但包含淋巴结区域的放疗平均食管平均剂量达11.4 Gy,可能近乎倍增食管癌风险。
要点
- 部分乳腺及乳腺/胸壁放疗的食管平均剂量通常低于2 Gy,辐射风险很小。
- 包含淋巴结区域的放疗平均食管平均剂量为11.4 Gy,可能近乎倍增食管癌风险。
- 淋巴结放疗计划中考虑食管受照可能降低辐射相关食管癌风险。
核心结论
- 部分乳腺和乳腺/胸壁放疗的食管平均剂量通常低于2 Gy,辐射风险很小;但包含淋巴结区域的放疗平均食管平均剂量达11.4 Gy,可能近乎倍增食管癌风险,计划时考虑食管受照可能降低风险。
研究设计与样本
- 对2010-2020年发表的乳腺癌放疗方案中食管剂量进行系统综述,共纳入18个国家112个已发表方案,按照射靶区和放疗技术描述食管平均剂量和最大剂量。
主要发现
- 部分乳腺照射4个方案的平均食管平均剂量为0.2 Gy(范围0.1-0.4),最大剂量未报告。
- 乳腺或胸壁放疗24个方案的平均食管平均剂量为1.8 Gy(范围0.1-10.4),7个方案的平均食管最大剂量为6.7 Gy(范围0.4-14.3)。
- 包含淋巴结区域放疗的61个方案平均食管平均剂量为11.4 Gy(范围<0.1-29.3),55个方案的平均食管最大剂量为34.4 Gy(范围3.4-51.3)。
- 调强淋巴结放疗的平均食管平均剂量>10 Gy,其他淋巴结放疗技术则较低。
临床怎么用
- 淋巴结放疗计划设计时应考虑食管受照剂量,以降低辐射相关食管癌风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Breast cancer radiotherapy can increase the risk of subsequent primary oesophageal cancer, with risk increasing according to oesophagus radiation dose. We describe oesophagus exposure from modern breast cancer regimens and discuss the risks of oesophageal cancer for women irradiated recently. MATERIALS AND METHODS: A systematic review was undertaken of oesophagus doses from breast cancer radiotherapy regimens published during 2010-2020. Mean and maximum oesophagus doses were described for different target regions irradiated and different radiotherapy techniques. RESULTS: In 112 published regimens from 18 countries, oesophagus doses varied with target region. For partial breast irradiation, average mean oesophagus dose was 0.2 Gy (range 0.1-0.4) in four regimens; maximum dose was not reported. For breast or chest wall radiotherapy, average oesophagus doses were mean 1.8 Gy (range 0.1-10.4) in 24 regimens and maximum 6.7 Gy (range 0.4-14.3) in seven regimens. For radiotherapy including a nodal region, average oesophagus doses were higher: mean 11.4 Gy (range <0.1-29.3) in 61 regimens and maximum 34.4 Gy (range 3.4-51.3) in 55 regimens. Average mean oesophagus doses were >10 Gy for intensity modulated nodal radiotherapy, but lower for other node techniques. CONCLUSIONS: Mean oesophagus doses from partial breast and breast/chest wall regimens were usually less than 2 Gy, hence radiation-risks will be very small. However, for radiotherapy including lymph nodes, average mean oesophagus dose of 11.4 Gy may nearly double oesophageal cancer risk. Consideration of oesophageal exposure during nodal radiotherapy planning may reduce the risks of radiation-related oesophageal cancer for women irradiated today.
引用
- Duane FK, Kerr A, Wang Z, et al. Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophagus doses published 2010-2020. Radiother Oncol. 2021. PMID: 34626725. doi:10.1016/j.radonc.2021.09.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。